Producing anti-cancer nano-drug by Iranian researchers

Tuesday, April 28, 2015 - 11:38

ISCA NEWS: A nano-drug has been produced by Iranian researchers which have proven effective in battling treatment resistant cancers. According to ISNA, Polymer-based nanocarriers for the targeted release of the anti-cancer drug curcumin have been produced by the Cancer Research Center of Tehran University of Medical Sciences.

f9308008-17bb-4cd9-a450-392d23aaecc5 Dr Ali Mohammad Alizadeh, the member of Iran Nanotechnology Initiative Council, stated: “This nanocarrier was made without the use of poisonous catalysts and has proven successful in clinical trials on a number cancer patients.” He also continued: “Research has proven that curcumin, which is found in turmeric, has anti-cancer and cancer preventing properties apart from its anti-oxidant and anti-inflammatory properties. When curcumin is prescribed in its edible form, it has a low effect on the targeted tissues because of its low absorption rate and fast metabolism which causes it to be flushed from the body. However, by capsuling curcumin in nano-emulsions (nano curcumin) its medical properties increase.” Doctor Alizade finally noted that: “because all the basic materials required manufacturing nano-curcumin are available in the country, it can be domestically mass-produced as an anti-cancer drug.”



Popular News

Latest News